PGC-1α, a bona-fide target of SIRT1, stimulates the neuromuscular gene program (NMJ), as a coactivator of GABP transcription factor, and counteracts the abnormalities of NMJ morphology in a muscular dystrophy model [19]. The gene discussed is PPARGC1A; the disease is muscular dystrophy.